Biological activity of 24,24-difluoro-1,25-dihydroxyvitamin D3.

[1]  E. Abe,et al.  1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). , 1982, The Biochemical journal.

[2]  H. DeLuca,et al.  Determination of biological activity of 24,24-difluoro-1,25-dihydroxyvitamin D3 in the chick using a new method for assessing intestinal calcium uptake. , 1982, Archives of biochemistry and biophysics.

[3]  A. Norman,et al.  Biological activity assessment of 25‐hydroxyvitamin D3‐26,23‐lactone in the rat , 1982 .

[4]  H. DeLuca,et al.  Bone resorptive activity of side-chain fluoro derivatives of 25-hydroxy- and 1 alpha,25-dihydroxyvitamin D3 in culture. , 1981, Molecular Pharmacology.

[5]  Etsuko Abe,et al.  1α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells , 1981 .

[6]  山田 幸子,et al.  Stereoselective synthesis and structure proof of a metabolite of vitamin D3, (23S,25R)-25-hydroxyvitamin D3 26,23-lactone (calcidiol lactone). , 1981 .

[7]  H. DeLuca,et al.  An examination of the importance of 24-hydroxylation to the function of vitamin D during early development. , 1981, Endocrinology.

[8]  M. Ohmori,et al.  Facile, stereoselective synthesis of (24R)-24,25-dihydroxyvitamin D3 using D-glyceric acid as a chiral synthon , 1981 .

[9]  H. DeLuca,et al.  Induction of calcium-binding protein in organ-cultured chick intestine by fluoro analogs of vitamin D3. , 1981, Archives of biochemistry and biophysics.

[10]  H. DeLuca,et al.  A fluorinated vitamin D3 analog with biopotency greater than 1α,25-dihydroxy vitamin D3 , 1980 .

[11]  H. DeLuca.  1 Vitamin D: Revisited 1980 , 1980 .

[12]  M. Ohmori,et al.  Synthesis of 24, 24-Difluoro-1α, 25-dihydroxyvitamin D3 , 1979 .

[13]  H. DeLuca.  Vitamin D metabolism and function. , 1979, Monographs on endocrinology.

[14]  R. Corradino.  Calcium-binding protein of intestine: induction by biologically significant cholecalciferol-like steroids in vitro. , 1978, Journal of steroid biochemistry.

[15]  S. Collins,et al.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture , 1977, Nature.

[16]  M. Haussler,et al.  Basic and clinical concepts related to vitamin D metabolism and action (second of two parts). , 1977, The New England journal of medicine.

[17]  H. Sheppard,et al.  Effect of hydroxy-vitamin D3 derivatives on 45Ca release from rat fetal bones in vitro. , 1977, Endocrinology.

[18]  A. Boris,et al.  Relative activities of some metabolites and analogs of cholecalciferol in stimulation of tibia ash weight in chicks otherwise deprived of vitamin D. , 1977, The Journal of nutrition.

[19]  J. Lotem,et al.  Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones , 1975, International journal of cancer.

[20]  J. Mason,et al.  The story of vitamin D: from vitamin to hormone. , 1974, Lancet.

[21]  H. DeLuca,et al.  Biological activity of 1,25-dihydroxyvitamin D3 in the rat. , 1973, Endocrinology.

[22]  Y. Ichikawa.  Differentiation of a cell line of myeloid leukemia , 1969, Journal of cellular physiology.

[23]  H. DeLuca,et al.  Influence of sodium on calcium transport by the rat small intestine. , 1969, The American journal of physiology.

[24]  E. F. Sabo,et al.  SYNTHESIS OF 17α-HYDROXYCORTICOSTERONE AND ITS 9α-HALO DERIVATIVES FROM 11-EPI-17α-HYDROXYCORTICOSTERONE , 1953 .

[25]  A. Norman,et al.  Vitamin D to 1,25-dihydroxycholecalciferol: evolution of a steroid hormone , 1979 .

[26]  M. Ohmori,et al.  Synthesis of 24,24-difluoro-25-hydroxyvitamin D3 , 1979 .

[27]  C. Kaneko.  A new synthetic method of 1a-hydroxy-7-dehydrocholesterol , 1974 .

[28]  J. Fried,et al.  Synthetic derivatives of cortical hormones. , 1958, Vitamins and hormones.